NRx Pharmaceuticals Inc. (NRXPW)

0.11

0.03 (35.47%)

At close: Mar 03, 2025, 1:27 PM

0.11

0.00%

After-hours: Mar 03, 2025, 01:27 PM EST

NRx Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-30.15M	-39.75M	-93.06M	-51.78M	408.43K	66.1K	-105.03K
Depreciation & Amortization	5K	4K	2K	2K	0.86	n/a	n/a
Stock-Based Compensation	387K	3.63M	7.79M	730K	933.90	n/a	n/a
Other Working Capital	2.51M	2.31M	-5.71M	3.1M	-66.68K	84.2K	-87K
Other Non-Cash Items	2.94M	-4.33M	54.28M	39.61M	-1.28M	-1.55M	-115.11K
Deferred Income Tax	n/a	n/a	-1.81M	5.72M	70.41K	n/a	n/a
Change in Working Capital	5.16M	699K	-4.9M	3.45M	4.66K	549.63K	-1.33K
Operating Cash Flow	-21.66M	-39.76M	-37.7M	-2.27M	-792.73K	-473.19K	-135.81K
Capital Expenditures	-3K	-10K	-7K	-2K	-3.55	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	-10K	-7K	n/a	-993.1K	-690K	-69M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	41.24M	42.39K	n/a
Other Investing Acitivies	n/a	10K	7K	26.18M	3.55	-647.61K	-69M
Investing Cash Flow	-3K	-10K	-7K	-2K	40.25M	-647.61K	-69M
Debt Repayment	-3.09M	9.5M	n/a	620K	n/a	690K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-40.73M	n/a	70.03M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.17M	22.71M	26.47M	50K	1.26M	n/a	n/a
Financial Cash Flow	6.2M	32.21M	63.46M	3.25M	-39.46M	682.5K	69.59M
Net Cash Flow	-15.46M	-7.55M	25.75M	982K	-11.07K	-438.3K	449.37K
Free Cash Flow	-21.66M	-39.77M	-37.71M	-2.27M	-792.73K	-473.19K	-135.81K